(2000) Clinical profile and long-term prognosis of women/or =50 years of age referred for coronary angiography for evaluation of chest pain. Gurevitz, O., Jonas, M., Boyko, V., Rabinowitz, B. (2000) Mild hypercholesterolemia and premature heart disease: Do the national criteria underestimate disease risk? Journal of the American College of Cardiology, 35, 1178-1184. Further enhanced strategies should be made for secondary prevention.Īkosah, K.O., Gower, E., Groon, L., Rooney, B.L.
Conclusions: PCAD patients implanted with DESs have mo re unstable clinical phenotypes and hi gher MACEs during a one-year follow-up period, though they were prescribed higher ratios of optimal therapeutic medicine. Logistic regression analyses showed that obesity (OR 1.757, 95% CI: 1.031 - 2.995), acute coronar y syndrome (OR 1.716, 95% CI: 1.011 - 2.913) and reduced left ventricular ejection fraction (OR 2.539, 95% CI: 1.180 - 5.463) predict MACEs in a one-year follow-up among patients with PCAD. Results: Compared with those receiving medicine alone, patients implanted with DESs had higher ratios of males than females, they also had acute coronary syndromes, multi-vessel disease, higher values of cardiac troponin I, longer hospital stays, higher aspirin and clopidogrel use (all P < 0.05) though these patients had higher use of aspirin and clopidogrel in the hospital and during follow-up and higher β -blockers and statins use during follow-up, they had higher ratios of recurrent angina and composite MACEs during one-year follow- up (all P < 0.05). Major adverse cardiovascular events (MACEs) and the use of medications for secondary prevention were collected and analyzed. Methods: 282 patients with PCAD, of which 177 implanted with DESs and 105 prescribed medicine alone were enrolled and analyzed.
This study was to evaluate clinical characteristics and one- year prognosis of PCAD implanted with DESs in a Chinese population. However, minimal data on the follow up results of premature coronary artery disease (PCAD) treated with DESs exist. Background: Drug-eluting stents (DESs) are associated with lower restenosis rates.
0 kommentar(er)
